Therefore, we can only extrapolate conclusions from the existing literature published on singleton pregnancies which thus far found that a fasting glucose level of 102.4 mg/dL and a 2-h glucose level of 194.4 mg/dL during the OGTT were predictive factors for the use of insulin in women diagnosed with GDM. The gene discussed is INS; the disease is gestational diabetes.